Global Journal of Cancer Therapy


Editorial

 

Novel Strategies to Improve Rituximab Efficacy in Non-Hodgkin's Lymphomas

 

Non-Hodgkin's lymphomas (NHLs) are the second fastest growing cancer in terms of incidence and deaths in the United States and Europe. NHLs are a heterogeneous cancer group including several haematological neoplasias with different degree of aggressiveness. In spite of the progresses, conventional therapies do not ensure long-term survival [1].

http://www.peertechz.com/Cancer-Therapy/GJCT-1-102.php

Comments

Popular posts from this blog

Successful treatment of Budd- Chiari Syndrome with Percutaneous transluminal Balloon Angioplasty

Case Report: Reynolds Syndrome

Ministernotomy Thymectomy in Mysthania Gravis-Future